Skip to main content
Premium Trial:

Request an Annual Quote

Joe Keegan

Courtagen Life Sciences has appointed Joe Keegan to its board of directors. Keegan served as CEO of protein analysis products firm ForteBio, which was sold to Pall in 2012, and was CEO of Molecular Devices for nine years, prior to that firm's acquisition in 2007 by MDS for $615 million. He also previously served as president of worldwide tissue culture and VP, general manager of worldwide flow cytometry for Becton Dickinson, and VP of the microscopy and scientific instruments division of Leica.